About Universität Tübingen; Med. Klinik; Innere Medizin I
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Universität Tübingen; Med. Klinik; Innere Medizin I
During the past decade, Universität Tübingen; Med. Klinik; Innere Medizin I conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Universität Tübingen; Med. Klinik; Innere Medizin I"
#1 collaborator was "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Universität Tübingen; Med. Klinik; Innere Medizin I
According to Clinical.Site data, the most researched conditions in "Universität Tübingen; Med. Klinik; Innere Medizin I" are
"Esophageal Squamous Cell Carcinoma" (1 trials), "Non-Hodgkin's Lymphoma" (1 trials) and "Unresectable Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "Universität Tübingen; Med. Klinik; Innere Medizin I" in a lesser frequency.
Clinical Trials Intervention Types at Universität Tübingen; Med. Klinik; Innere Medizin I
Most popular intervention types in "Universität Tübingen; Med. Klinik; Innere Medizin I" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Atezolizumab Matching Placebo" (1 trials), "Bendamustine" (1 trials), "Cyclophosphamide" (1 trials) and "Doxorubicin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Universität Tübingen; Med. Klinik; Innere Medizin I
The vast majority of trials in "Universität Tübingen; Med. Klinik; Innere Medizin I" are
3 trials for "All" genders.
Clinical Trials Status at Universität Tübingen; Med. Klinik; Innere Medizin I
Currently, there are NaN active trials in "Universität Tübingen; Med. Klinik; Innere Medizin I".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Universität Tübingen; Med. Klinik; Innere Medizin I,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Universität Tübingen; Med. Klinik; Innere Medizin I, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".